Trials / Active Not Recruiting
Active Not RecruitingNCT05462951
Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
Phase 0 Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 19 (actual)
- Sponsor
- Denise Fabian · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer. Women receive standard-of-care radiochemotherapy followed by brachytherapy. Blood samples are obtained to detect circulating levels of deoxyribonucleotides, human papillomavirus DNA, and circulating tumor cells.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Standard | Radiation then brachytherapy |
Timeline
- Start date
- 2023-01-03
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2022-07-18
- Last updated
- 2025-11-28
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05462951. Inclusion in this directory is not an endorsement.